Author Archives: cnorton

FRaBSA Webinar

FRaBSA will NOT be holding our spring meeting. We will, however, be holding a webinar on Friday, April 24 12:00 – 1:30 pm Join us via Zoom Join URL: https://zoom.us/j/849687963 Questions? Issues logging in?  contact Communications@frabsa.org

Posted in Uncategorized | Leave a comment

NIH Guideline Updates

April 25, 2019, the National Institutes of Health (NIH) finalized a proposal to amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) to streamline the oversight of gene therapy research. This proposal, which was … Continue reading

Posted in Uncategorized | Leave a comment

2017 Symposium

The FRaBSA Inaugural Biosafety Symposium was held September 29, 2017 in Boulder, CO. Agenda and links to the video are available in the members only section. click here

Posted in Uncategorized | Leave a comment

ABSA Risk Group Database App

Risk Group Database App FREE for iTunes and Android! ABSA International created an app for the ABSA Risk Group Database, which is available for Apple and Android devices. The app will allow users to access the ABSA Risk Group Database … Continue reading

Posted in Announcements | Leave a comment

Everett Hanel, Jr. Presidential Award

Biosafety director earns acclaim for securing research pathogens | SOURCE <style> .wpb_animate_when_almost_visible { opacity: 1; }</style> The Colorado State University officer charged with protecting researchers and the public from infectious research pathogens has received international honors for effective safeguards that … Continue reading

Posted in Announcements | Tagged , , | Leave a comment

HHS selects nine regional Ebola and other special pathogen treatment centers

http://www.hhs.gov/news/press/2015pres/06/20150612b.html HHS selects nine regional Ebola and other special pathogen treatment centers • Colorado Department of Public Health and Environment in partnership with Denver Health Medical Center in Denver, Colorado

Posted in Uncategorized | Leave a comment